Pharmacogenomics, Volume 13, Issue 14 (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Pharmacogenomics, Volume 13, Issue 14 (2012)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Volume 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 24, 2023 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 2000
Download citations Download PDFs Download issue

Editorial

Editorial
The Future of Thiopurine Pharmacogenomics
John A Duley, Andrew A Somogyi & Jennifer H Martin
Pages: 1549-1552
Published online: 13 Nov 2012
First Page PreviewforThe Future of Thiopurine Pharmacogenomics | Full Text | References | PDF (914.7 KB)
  • 943 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Bladder Cancer Pharmacogenomics: Recent Insights and Future Perspectives
Peter H O‘Donnell
Pages: 1553-1556
Published online: 13 Nov 2012
First Page PreviewforBladder Cancer Pharmacogenomics: Recent Insights and Future Perspectives | Full Text | References | PDF (683.7 KB)
  • 199 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Editorial
Influence of the CYP2C9*3 Allele on the Pharmacological Interaction Between Warfarin and Simvastatin
Mariana Rodrigues Botton, Mara Helena Hutz & Guilherme Suarez-Kurtz
Pages: 1557-1559
Published online: 13 Nov 2012
AbstractforInfluence of the CYP2C9*3 Allele on the Pharmacological Interaction Between Warfarin and Simvastatin | Full Text | References | PDF (639.5 KB)
  • 1001 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Influence of the CYP2C9*3 Allele on the Pharmacological Interaction Between Warfarin and Simvastatin: Author Reply
Marine L Andersson, Erik Eliasson & Jonatan D Lindh
Pages: 1561-1562
Published online: 13 Nov 2012
AbstractforInfluence of the CYP2C9*3 Allele on the Pharmacological Interaction Between Warfarin and Simvastatin: Author Reply | Full Text | References | PDF (571.8 KB)
  • 409 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

News & Views

News
News & Views in … Pharmacogenomics
Pages: 1563-1565
Published online: 13 Nov 2012
First Page PreviewforNews & Views in … Pharmacogenomics | Full Text | PDF (1.1 MB)
  • 333 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
News
Research Highlights: Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity
Ana Alfirevic, B Kevin Park, Munir Pirmohamed & Dean J Naisbitt
Pages: 1567-1569
Published online: 13 Nov 2012
First Page PreviewforResearch Highlights: Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity | Full Text | References | PDF (581.1 KB)
  • 404 Views
  • 0 CrossRef citations
  • 0Altmetric

Research Article

Article
Genetic Polymorphisms and Novel Allelic Variants of CYP2C19 in the Chinese Han Population
Li-Ming Hu, Da-Peng Dai, Guo-Xin Hu, Jie-Fu Yang, Ren-Ai Xu, Li-Ping Yang, Jian-Chang Qian, Ren-Shan Ge & Jian-Ping Cai
Pages: 1571-1581
Published online: 13 Nov 2012
AbstractforGenetic Polymorphisms and Novel Allelic Variants of CYP2C19 in the Chinese Han Population | Full Text | References | PDF (937.3 KB) | Supplemental
  • 353 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Genetic Variation in the SLC19A1 gene and Methotrexate Toxicity in Rheumatoid Arthritis Patients
Petra Bohanec Grabar, Luis J Leandro-García, Lucía Inglada-Pérez, Dušan Logar, Cristina Rodríguez-Antona & Vita Dolžan
Pages: 1583-1594
Published online: 13 Nov 2012
AbstractforGenetic Variation in the SLC19A1 gene and Methotrexate Toxicity in Rheumatoid Arthritis Patients | Full Text | References | PDF (1.2 MB) | Supplemental
  • 246 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Association of ERCC1 SNPs with Outcome in Platinum-Treated Patients with Advanced Urothelial Cancer: A Hellenic Cooperative Oncology Group Study
Nikitas Nikitas, Alexandra Karadimou, Eliza Tsitoura, Nikolaos Soupos, Marinos Tsiatas, Vasilios Karavasilis, Dimitrios Pectasides, Nikolaos Pavlidis, Michael Chrisofos, Ioannis Adamakis, Samuel Murray, Georgios Fountzilas, Meleios-Athanasios Dimopoulos & Aristotle Bamias
Pages: 1595-1607
Published online: 13 Nov 2012
AbstractforAssociation of ERCC1 SNPs with Outcome in Platinum-Treated Patients with Advanced Urothelial Cancer: A Hellenic Cooperative Oncology Group Study | Full Text | References | PDF (1.1 MB)
  • 114 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Polymorphic Thymidylate Synthase Gene Impacts on Overall Survival of Patients with Epithelial Ovarian Cancer After Platinum-Based Chemotherapy
Paola Biason, Michele Visentin, Renato Talamini, Alex Stopar, Giorgio Giorda, Emilio Lucia, Elio Campagnutta & Giuseppe Toffoli
Pages: 1609-1619
Published online: 13 Nov 2012
AbstractforPolymorphic Thymidylate Synthase Gene Impacts on Overall Survival of Patients with Epithelial Ovarian Cancer After Platinum-Based Chemotherapy | Full Text | References | PDF (1.4 MB)
  • 121 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Constitutional Genetic Variants as Predictors of Antiangiogenic Therapy Outcome in Renal Cell Carcinoma
Cristina Rodríguez-Antona & Jesús García-Donas
Pages: 1621-1633
Published online: 13 Nov 2012
AbstractforConstitutional Genetic Variants as Predictors of Antiangiogenic Therapy Outcome in Renal Cell Carcinoma | Full Text | References | PDF (1.1 MB)
  • 450 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
miRNA Pharmacogenomics: The New Frontier for Personalized Medicine in Cancer?
Eva Dreussi, Paola Biason, Giuseppe Toffoli & Erika Cecchin
Pages: 1635-1650
Published online: 13 Nov 2012
AbstractformiRNA Pharmacogenomics: The New Frontier for Personalized Medicine in Cancer? | Full Text | References | PDF (1.5 MB)
  • 483 Views
  • 0 CrossRef citations
  • 0Altmetric

Perspective

Review Article
Building Bridges to the Future of Medicine: Recommendations for Boosting Development of Novel and Companion Diagnostics
James Creeden
Pages: 1651-1659
Published online: 13 Nov 2012
AbstractforBuilding Bridges to the Future of Medicine: Recommendations for Boosting Development of Novel and Companion Diagnostics | Full Text | References | PDF (782.2 KB)
  • 176 Views
  • 0 CrossRef citations
  • 0Altmetric

Acknowledgements

Acknowledgements
Page: 1661
Published online: 13 Nov 2012
CitationforAcknowledgements | Full Text | PDF (65.3 KB)
  • 88 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Rapid point of care testing: the next frontier in pharmacogenomics
Marc Leach et al.
Editorial | Published online: 23 Jul 2024
Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention
Joshua J Park et al.
Article | Published online: 6 Jun 2024
A critical review of RAF inhibitors in BRAF-mutated glioma treatment
John-Victor El Khoury et al.
Review Article | Published online: 3 Jun 2024
Impact of CYP2D6 and ADRB1 polymorphisms on heart rate of post-PCI patients treated with metoprolol
Xiaofeng Gao et al.
Article | Published online: 31 May 2024
View all latest articles